Literature DB >> 18318679

Correlation of autoantibodies presence detected by IFA-anti-dsDNA, IFA-AMA and immunoblotting with corresponding data in clinical management of autoimmune diseases.

Demo Subasić1, Jasenko Karamehić, Farid Ljuca, Faris Gavrankapetanović, Marina Delić-Sarac, Izet Eminović, Dragan Kovacević.   

Abstract

Diagnosis and management of patients with SLE (Systemic Lupus Eritematosus), autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), involves specific diagnostic tests, such as IFA-AMA, IFA anti-dsDNA and immunoblotting for the detection of autoantibodies for specific autoantigens (mitochondria, dsDNA, M2, LKM-1, LC-1, SLA/LP). We established specific correlation between the detected autoantibodies and corresponding clinical findings. The total of 813 serum specimens were probed with IFA-anti-dsDNA, 98 of which tested positive. We also performed dilution analysis to the end point for all the positive specimens. Numerous specimens were tested by IFA, AMA and immunoblotting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18318679      PMCID: PMC5724883          DOI: 10.17305/bjbms.2008.3004

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  13 in total

Review 1.  Tolerance and autoimmunity.

Authors:  T Kamradt; N A Mitchison
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

Review 2.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

3.  Evidence for absence of histones in the Crithidia luciliae kinetoplast: a study with anti-H2A and monoclonal anti-H3 antibodies.

Authors:  K N Konstantinov; V R Russanova
Journal:  Br J Dermatol       Date:  1987-10       Impact factor: 9.302

4.  An immunofluorescence procedure for the demonstration of antibodies to native, double-stranded DNA and of circulating DNA-anti-DNA complexes.

Authors:  G Stingl; J G Meingassner; P Swelty; W Knapp
Journal:  Clin Immunol Immunopathol       Date:  1976-09

5.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

Review 6.  Autoimmunity and primary biliary cirrhosis.

Authors:  I R Mackay
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  2000-08

7.  Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.

Authors:  P Lapierre; O Hajoui; J C Homberg; F Alvarez
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

Review 10.  Conceptual framework for evaluating laboratory tests: case-finding in ambulatory patients.

Authors:  M D Silverstein; B J Boland
Journal:  Clin Chem       Date:  1994-08       Impact factor: 8.327

View more
  2 in total

Review 1.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 2.  Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Masaaki Takamura; Yutaka Aoyagi
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.